Today, it appears Paul will be in Texas discussing the "breakthrough's" related to the delivery of antibodies with the Tethadur platform. I don't see any of PSDV's competition claiming this ability. This is how we'll move from micro cap to small cap overnight boys and girls. Hold on to your shares.
Homeboy, Yes, it seems so. When Paul Ashton talks it seems people listen. How fast can we separate ourselves from ALIM? I think the preclinical's are starting to get some traction. The evaluation agreements must be producing data that PSDV is free to share at such conferences. Paul, with his very mild manner delivery, is increasing his shots on goal with all the kids in the playground.